We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+1.62%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.67B
AUM Growth
-$9.35M
Cap. Flow
-$34.4M
Cap. Flow %
-0.94%
Top 10 Hldgs %
14.32%
Holding
1,376
New
77
Increased
503
Reduced
565
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 13.32%
2 Healthcare 11.6%
3 Financials 11.11%
4 Consumer Discretionary 8.81%
5 Industrials 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JRS icon
1201
Nuveen Real Estate Income Fund
JRS
$246M
$125K ﹤0.01%
11,379
-2,659
-19% -$28.4K
TCRT icon
1202
Alaunos Therapeutics
TCRT
$4.86M
$125K ﹤0.01%
193
+6
+3% +$4.76K
CHI
1203
Calamos Convertible Opportunities and Income Fund
CHI
$1.05B
$124K ﹤0.01%
+11,892
New +$125K
HIE
1204
DELISTED
Miller/Howard High Income Equity Fund
HIE
$123K ﹤0.01%
11,250
DLTH icon
1205
Duluth Holdings
DLTH
$159M
$117K ﹤0.01%
13,830
-1,400
-9% -$15.3K
CTR
1206
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
$113K ﹤0.01%
2,527
+100
+4% +$4.54K
JRO
1207
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$113K ﹤0.01%
11,825
-2,917
-20% -$28K
CMCM
1208
Cheetah Mobile
CMCM
$96.5M
$111K ﹤0.01%
6,204
WATT icon
1209
Energous
WATT
$102M
$111K ﹤0.01%
56
+10
+22% +$23.3K
SCOR icon
1210
Comscore
SCOR
$109M
$105K ﹤0.01%
2,750
-750
-21% -$43.3K
GRCE
1211
Grace Therapeutics
GRCE
$34.7M
$104K ﹤0.01%
+1,149
New +$106K
JPS
1212
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$103K ﹤0.01%
10,490
-1,350
-11% -$13.1K
SBBP
1213
DELISTED
Strongbridge Biopharma plc.
SBBP
$102K ﹤0.01%
42,731
+398
+0.9% +$1.07K
LGF.A
1214
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$96K ﹤0.01%
10,400
-700
-6% -$7.97K
CLVS
1215
DELISTED
Clovis Oncology, Inc.
CLVS
$96K ﹤0.01%
24,540
-5,415
-18% -$43.8K
NML
1216
Neuberger Energy Infrastructure and Income Fund Inc
NML
$576M
$93K ﹤0.01%
12,889
-1,124
-8% -$8.13K
HEXO
1217
DELISTED
HEXO Corp. Common Shares
HEXO
$92K ﹤0.01%
414
-16
-4% -$3.99K
BGG
1218
DELISTED
Briggs & Stratton Corp.
BGG
$91K ﹤0.01%
15,004
-5,400
-26% -$39.9K
PPT
1219
Franklin Premier Income Trust
PPT
$328M
$86K ﹤0.01%
16,261
-908
-5% -$4.78K
ANGI icon
1220
Angi Inc
ANGI
$196M
$83K ﹤0.01%
1,170
+45
+4% +$4.62K
SAN icon
1221
Banco Santander
SAN
$210B
$83K ﹤0.01%
21,608
-1,743
-7% -$6.92K
ROYT
1222
DELISTED
PACIFIC COAST OIL TRUST
ROYT
$79K ﹤0.01%
+40,295
New +$85K
QEP
1223
DELISTED
QEP RESOURCES, INC.
QEP
$77K ﹤0.01%
20,800
VNRX icon
1224
VolitionRx Ltd
VNRX
$9.34M
$72K ﹤0.01%
638
-1,344
-68% -$107K
KOPN icon
1225
Kopin
KOPN
$791M
$69K ﹤0.01%
102,500
+5,000
+5% +$4.99K

Similar funds

Oppenheimer & Co's Q3 2019 Portfolio in Review

As of Q3 2019, Oppenheimer & Co held 1,376 positions worth $3.67B, down 0.25% from $3.68B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2019 filing shows 77 new, 503 increased, 565 reduced and 124 closed positions. Its largest new stake was Aramark: 104,734 shares worth $3.3M. The largest sale was Cisco, an estimated $6.15M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q3 2019 buy was Aramark: 104,734 shares worth $3.3M.
  • Oppenheimer & Co added most to Target in Q3 2019, an estimated $5.22M increase.
  • Oppenheimer & Co's biggest Q3 2019 reduction was Cisco, cutting an estimated $6.15M.
  • Oppenheimer & Co fully exited L3 Technologies, Inc. in Q3 2019, selling an estimated $5.21M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.67B portfolio in Q3 2019.
  • Oppenheimer & Co opened 77 new positions and closed 124 in Q3 2019.
  • Oppenheimer & Co's portfolio value fell 0.25% quarter-over-quarter to $3.67B.

Based on Oppenheimer & Co's 13F filing for Q3 2019, filed 31 Oct 2019.